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Case report Neonatal arterial iliac thrombosis in type-I protein 
C deficiency: a case report
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Abstract
A male infant born by caesarean section at 38 weeks of gestational age (B.W. 4055 g; Apgar 9-10), in the first two hours 
of life his right leg became hypovascularizated.
Normal values of leukocities, red cells, haematocrit, hemoglobin, platelets. C-Reactive Protein negative. Electrolytes and 
coagulation tests were normal. Normal vitamin K coagulation proteins levels. Serological tests for TORCH (IgM) and 
Parvovirus (IgG and IgM) were negative.
Sonography showed a reduced blood flow in the iliac artery and reported a 1 cm long vessel thrombosis.
From 8 hours of life we administred an intravenous infusion of unfractionated heparin (UFH) 75 UI/Kg for the first 10 
minutes then 28 UI/Kg/h.
On the 2nd day tests were performed to assess absence of inhibiting-clot factors. The dosage of homocysteine, protein 
S and antithrombin was normal. FV Leiden and antiphospholipid antibodies were negative. The mapping of G20210A 
prothrombin's gene resulted normal, whereas the concentration of Protein C was lower than normal: activity 46% (68-
150%), antigen 35% (70-150%).
The same deficiency was also found in the father. The mother showed normal concentrations. No episodies of 
thrombosis events were documentated in the family.
The intravenous unfractionated heparin (UFH) therapy was replaced after 64 hours by subcutaneous nadroparin 600 UI 
twice/day, which was stopped 5 days later when the vessel sonografic images were completely normal. During the 
hospitalization the infant didn't show bleeding.
The child was followed-up yearly until 4 years of age: he was well and had a normal body and mental development.
The final diagnosis is likely to be of a permanent protein C deficiency in heterozygous form. Our case is interesting 
because the first manifestation was an important thrombosis of large vessel that occurred within a few hours of life in 
absence of perinatal risk factors, as if it was a homozygous disease, but the patient had a heterozygotic form. In 
literature few cases are reported of heterozygous forms that became symptomatic, but only in old age.
After a severe first manifestation, a normal and asymptomatic development is uncommon without new thrombotic 
episodes. In our patient the neonatal thrombosis was the sole event in his life.
Introduction
In the neonatal period thrombosis is a rare event. In two
registers from Canada and Germany [1,2] the incidence
of this pathology was respectly 2.4/1000 admission to
NICU and 5.1/100000 births. The main causes are the
presence of central line, asphyxia, septicaemia, dehydra-
tion and maternal diabetes.
Anormalities of antithrombin and the protein C system
have been documented in association with spontaneous
neonatal thrombotic problems.
Protein C deficiency is a genetic trait that predisposes
to the formation of venous or arterial clots.
There are two kinds of Protein C deficiency: type I and
type II. Type I deficiency results from an inadequate
amount of protein C, that functions normally, but the
quantity of protein C present is insufficient to control the
coagulation cascade. Type II deficiency is characterized
by defective protein C molecules: the protein C level is
normal, but it's unable to interact with the other mole-
cules involved in coagulation.
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Case Report
A male infant born by caesarean section at 38 weeks of
gestational age and with a birth weight of 4055 g (Apgar
Score: 9 at 1' and 10 at 5'), was referred to our NICU
because in the first two hours of life his right leg became
pale, hypothermic and cyanotic and oxygen saturation
was lower than in the other limbs (70-80% vs. 98-100%).
Maternal vaginal scrub was negative for Agalactie
group B Streptococcus and maternal screening for the
common infections had negative results (HBV negative,
HIV negative, CMV immune, Rubella virus immune,
Toxoplasma Gondii not immune, Syphilis negative). No
desease was referred during the pregnagny.
At birth a single intramuscular dose of vitamin K was
administered as antihaemorrhagic prophylaxis on the left
thigh.
The hypovascularization of his right leg was confirmed,
even though he wasn't in immediate danger when he was
admitted.
Laboratory studies revealed normal values of leukoci-
ties, red cells, haematocrit, hemoglobin, platelets. (White
Blood Cells 13.080/mmc: N 68.5%, L 24.7%, M 3.6%, E
1.2%, B 0.9%; Red Cells 5.660.000/mmc, Hb 19.1 g/dl, Hct
56.2%, PLT 158.000/mmc). C-Reactive Protein negative.
Electrolytes and coagulation tests were normal: aPTT-
ratio 1.09 range (0.8-1.20); PT% 70% (70-100%); INR 1.27
(0.92-1.30). Our laboratory found normal vitamin K
coagulation proteins levels (FII, FV, FVII, FVIII, FIX, FX,
FXI, FXII). Serological tests for TORCH (IgM) and Par-
vovirus (IgG and IgM) were negative.
Sonography showed a reduced blood flow in the iliac
artery and reported a 1 cm long vessel thrombosis. His
heart and other arteries appeared to be normal. Cerebral
and renal ultrasound findings were normal.
From 8 hours of life we administred an intravenous
infusion of unfractionated heparin (UFH) 75 UI/Kg for
the first 10 minutes then 28 UI/Kg/h.
On the 2nd day tests were performed to assess presence/
absence of inhibiting-clot factors. The dosage of homo-
cysteine, protein S and antithrombin was normal. FV
Leiden and antiphospholipid antibodies were negative.
The mapping of G20210A prothrombin's gene resulted
normal, whereas the concentration of Protein C was
lower than normal: activity 46% (normal range 68-150%),
antigen 35% (70-150%).
The same deficiency was also found in the father: activ-
ity 61%, antigen 50%, but he was asymptomatic. The
mother showed normal protein C concentrations. No
episodies of thrombosis or other thromboembolic events
were documentated in father's family.
The newborn showed both a clinical and sonographic
gradual improvement.
The intravenous unfractionated heparin (UFH) therapy
was replaced after 64 hours by subcutaneous nadroparin
600 UI twice/day, which was stopped 5 days later when
the vessel sonografic images were completely normal.
The patient was discharged from the hospital after 10
days with a year long prophylactic 20 mg/day oral dose of
aspirin. During the hospitalization the infant didn't show
bleeding, the cerebral sonography at the discharge
resulted normal. The child was followed-up yearly until 4
years of age: he was well and had a normal body and men-
tal development. Therapy with plasma or protein C was
never necessary.
During the observational period the concentration of
Protein C was confirmed low: at 1 year of life activity was
46% and antigen was 35%; at 2 years activity 47% and anti-
gen 48%, at 3 years activity 52% and antigen 50%, at 4
years activity 40% and antigen 34%.
Discussion
The protein C levels gradually improve during life [3].
Protein C concentration is 15% of the adult level in the
infant, 35% in the premature newborn, 80% in the adoles-
cent and it improves by 4% every 10 years [4,5].
Protein C deficiency is present in approximately 0.2% of
the population. This rate includes asymptomatic people
and patients with severe thrombotic disease. Symptoms
depend on the genetic mutation on the chromosome 2
q13-q14. People with heterozygous form can usually live
all their life without clinical problems. The classical neo-
natal manifestation of homozygous protein C deficiency
is a severe form of thrombosis of the large vessels or a
purpura fulminans that occurs within a few hours or days
of life, causing tissue necrosis and gangrenous and dis-
seminated intravascular coagulation [3,6,7].
Treatment of a patient with protein C deficiency
depends on the individual patient's risk of thromboembo-
lic disease.
In patients with homozygous form the risk of death
from thrombosis is imminent. As a result, treatment is
based on providing a source of Protein C [3]. This can be
done with fresh frozen plasma (FFP) or with human
plasma protein C concentrate. At this time there are still
no studies that compare the use of the protein C concen-
trates versus FFP in severe protein C deficiency related
thrombosis.
The treatment of deep thrombosis is commonly
defined in a bolus dose of unfractionated heparin (UFH)
from 75 to 100 U/kg and a maintenance dose of 28 U/Kg/
h for newborns or 20 U/Kg/h for children >1 year of age
[8]. The few studies on UFH in newborns show that the
clearance is faster than that for older children due to a
larger volume of distribution [9,10]. Also pharmacoki-
netic research shows the same different UFH clearance
between piglets and adult pigs [11].
An alternative recommendation is the only supportive
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show an extension of the thrombosis [8]. Central venous
line should be removed if possible.
In our case report the final diagnosis is likely to be of a
permanent protein C deficiency in heterozygous form,
especially considering the patient's clinical history and
father's protein C levels. Our case is interesting because
the first manifestation was an important thrombosis of
large vessel that occurred within a few hours of life in
absence of perinatal risk factors, as if it was a homozy-
gous disease, but the patient had a heterozygotic form. In
literature [6,8,11-14], thought the clinical pattern of
heterozygous disease is commonly described as very vari-
able, few cases are reported of heterozygous forms that
became symptomatic, but only in old age.
After a severe first manifestation of the thrombosis a
normal and asymptomatic development is uncommon
without new thrombotic episodes. In our patient the neo-
natal thrombosis was the sole event in his life. The child
has grown well until now without physical or mental
problems.
As these patients are often asymptomatic, to perform
coagulation tests and the dosage of protein C on parents
is the only way to identify newborns with a high risk of
fatal thrombotic events. Further epidemiological studies
are necessary to asses the real benefit/cost ratio of a
parental prenatal screening to diagnose neonatal cases
and to begin therapy sooner.
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